Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2577-2583

  Lin, W Michael ^a,b   Forgacs, Eva ^b   Warshal, David P ^c   Yeh, I Tien ^c   Martin, Joilyn S ^c   Ashfaq, Raheela ^a   Muller, Carolyn Y ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c ABINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CHROMOSOME 10Q; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; METASTASIS; MUTATION; OVARY CARCINOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; PHOSPHORIC MONOESTER HYDROLASES; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PTEN PHOSPHOHYDROLASE; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031724674     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Eisner, R. F., Nieberg, R. K., and Berek, J. S. Synchronous primary neoplasms of the female reproductive tract. Gynecol. Oncol., 33: 335-339, 1989.
2. Ayhan, A., Yalcin, O. T., Tuncer, Z. S., Gurgan, T., and Kucukali, T. Synchronous primary malignancies of the female genital tract. Eur. J. Obstet. Gynecol. Reprod. Biol., 45: 63-66, 1992.
3. Czernobilsky, B., Silverman, B. B., and Mikuta, J. J. Endometrioid carcinoma of the ovary. A clinicopathologic study of 75 cases. Cancer (Phila.), 26: 1141-1152, 1970.
4. Kline, R. C., Wharton, J. T., Atkinson, E. N., Burke, T. W., Gershenson, D. M., and Edwards, C. L. Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol. Oncol., 39: 337-346, 1990.
5. Pearl, M. L., Johnston, C. M., Frank, T. S., and Roberts, J. A. Synchronous dual primary ovarian and endometrial carcinomas. Int. J. Gynaecol. Obstet., 43: 305-312, 1993.
6. Falkenberry, S. S., Steinhoff, M. M., Gordinier, M., Rappoport, S., Gajewski, W., and Granai, C. O. Synchronous endometrioid tumors of the ovary and endometrium. A clinicopathologic study of 22 cases. J. Reprod. Med., 41: 713-718, 1996.
7. Garzetti, G. G., Ciavattini, A., Goteri, G., De Nictolis, M., Cignitti, M., Tranquilli, A. L., and Romanini, C. Endometrioid carcinoma of the ovary. Retrospective study. Eur. J. Gynaecol. Oncol., 14: 51-55, 1993.
8. Choo, Y. C., and Naylor, B. Multiple primary neoplasms of the ovary and uterus. Int. J. Gynaecol. Obstet., 20: 327-334, 1982.
9. Gitsch, G., Hanzal, E., Jensen, D., and Hacker, N. F. Endometrial cancer in premenopausal women 45 years and younger. Obstet. Gynecol., 85: 504-508, 1995.
10. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S., Giovanella, B., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275:1943-1947, 1997.
11. Steck, P., Pershouse, M., Jasser, S., Yung, W., Lin, H., Ligon, A., Langford, L., Baumgard, M., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D., and Tavtigian, S. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
12. Guldberg, P., thor Straten, P., Birck, A., Ahrenkiel, V., Kirkin, A. F., and Zeuthen, J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res., 57: 3660-3663, 1997.
13. Tashiro, H., Blazes, M., Wu, R., Cho, K., Bose, S., Wang, S., Li, J., Parsons, R., and Ellenson, L. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res., 57: 3935-3940, 1997.
14. Rhei, E., Kang, L., Bogomolniy, F., Federici, M. G., Borgen, P. I., and Boyd, J. Mutation analysis of the putative tumor suppressor gene PTEN/ MMAC1 in primary breast carcinomas. Cancer Res., 57: 3657-3659, 1997.
15. Forgacs, E., Biesterveld, E., Sekido, Y., Fong, K., Muneer, S., Wistuba, I., Milchgrub, S., Brezinschek, R., Virmani, A., Gazdar, A., and Minna, J. Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene, 17: 1557-1565, 1998.
16. Arch, E. M., Goodman, B. K., Van Wesep, R. A., Liaw, D., Clarke, K., Parsons, R., McKusick, V. A., and Geraghty, M. T. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am. J. Med. Genet., 71: 489-493, 1997.
17. Dahia, P., Marsh, D., Zheng, Z., Zedenius, J., Komminoth, P., Frisk, T., Wallin, G., Parsons, R., Longy, M., Larsson, C., and Eng, C. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid Tumors. Cancer Res., 57: 4710-4713, 1997.
18. Marsh, D. J., Dahia, P. L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., and Eng, C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet., 16: 333-334, 1997.
19. Risinger, J., Hayes, A., Berchuck, A., and Barrett, J. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res., 57: 4736-4738, 1997.
20. Sakurada, A., Suzuki, A., Sato, M., Yamakawa, H., Orikasa, K., Uyeno, S., Ono, T., Ohuchi, N., Fujimura, S., and Horii, A. Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary. Jpn. J. Cancer Res., 88: 1025-1028, 1997.
21. Obata, K., Morland, S. J., Watson, R. H., Hitchcock, A., Chenevix-Trench, G., Thomas, E. J., and Campbell, I. G. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res., 58: 2095-2097, 1998.
22. Creasman, W. T. Announcement, FIGO stages, revisions. Gynecol. Oncol., 35: 125-127, 1989.
23. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 273: 1908, 1995.
24. Wistuba, I. I., Behrens, C., Milchgrub, S., Virmani, A. K., Jagirdar, J., Thomas, B., Ioachim, H. L., Litzky, L. A., Brambilla, E. M., Minna, J. D., and Gazdar, A. F. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. J. Am. Med. Assoc., 279: 1554-1559, 1998.
25. Symonds, D. A., Johnson, D. P., and Wheeless, C. R., Jr. Feulgen cytometry in simultaneous endometrial and ovarian carcinoma. Cancer (Phila.), 61: 2511-2516, 1988.
26. Fujita, M., Enomoto, T., Wada, H., Inoue, M., Okudaira, Y., and Shroyer, K. R. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am. J. Clin. Pathol., 105: 350-359, 1996.
27. Emmert-Buck, M. R., Chuaqui, R., Zhuang, Z., Nogales, F., Liotta, L. A., and Merino, M. J. Molecular analysis of synchronous uterine and ovarian endometrioid tumors. Int. J. Gynecol. Pathol., 16: 143-148, 1997.
28. Shenson, D. L., Gallion, H. H., Powell, D. E., and Piererti, M. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer (Phila.), 76: 650-657, 1995.
29. Morrow, C. P., Bundy, B. N., Kurman, R. J., Creasman, W. T., Heller, P., Homesley, H. D., and Graham, J. E. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol. Oncol., 40: 55-65, 1991.
30. Kurman, R. J., Zaino, R. J., and Norris, H. J. Blaustein's Pathology of the Female Genital Tract, Ed. 4, pp. 439-486. New York: Springer-Verlag, 1994.